166 related articles for article (PubMed ID: 6644793)
41. Circulating immune complexes in patients with usual interstitial pulmonary fibrosis: partial characterization and relationship with Thermoactinomyces vulgaris.
Cocchiara R; Giallongo A; Amoroso S; Spina G; Stancampiano R; Geraci D
Immunology; 1981 Dec; 44(4):817-25. PubMed ID: 7319561
[TBL] [Abstract][Full Text] [Related]
42. Polymorphonuclear functions in Hodgkin's disease patients at diagnosis, in remission, and in relapse.
Corberand J; Benchekroun S; Nguyen F; Laharrague P; Pris J
Cancer Res; 1982 Apr; 42(4):1595-9. PubMed ID: 7060029
[TBL] [Abstract][Full Text] [Related]
43. Circulating immune complexes and peripheral B lymphocytes in non insulin dependent diabetic patients.
Barañao RI; Tesone PA; Chasseing NA; Mendelson M; Rumi LS
Acta Physiol Lat Am; 1983; 33(2):111-6. PubMed ID: 6230879
[TBL] [Abstract][Full Text] [Related]
44. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
Bockman RS
J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
[TBL] [Abstract][Full Text] [Related]
45. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
[TBL] [Abstract][Full Text] [Related]
46. [Immunological data in the clinical evaluation of Hodgkin's diseases].
Burchardt K
Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
[TBL] [Abstract][Full Text] [Related]
47. Alterations of immunologic parameters in pregnancies complicated by EPH-gestosis.
Bartl W; Bernaschek G; Wagner G; Liszka K
Biol Res Pregnancy Perinatol; 1985; 6(2):73-8. PubMed ID: 3893553
[TBL] [Abstract][Full Text] [Related]
48. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
49. [Interdependency between titers of aniretinal antibodies and selected immune system parameters in serum of patients with endogenous posterior uveitis].
Kubicka-Trzaska A
Klin Oczna; 2000; 102(4):259-62. PubMed ID: 11291296
[TBL] [Abstract][Full Text] [Related]
50. Circulating immune complexes in Hodgkin's disease.
Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
[TBL] [Abstract][Full Text] [Related]
51. Follow-up of circulating immune complexes in the course of acute viral hepatitis, and correlation with serologically relevant parameters.
Manca F; Cauda R; Laghi V; Cantarella S; Trovatello G; Ortona L; Celada F
Hepatogastroenterology; 1984 Jun; 31(3):119-22. PubMed ID: 6432669
[TBL] [Abstract][Full Text] [Related]
52. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
[TBL] [Abstract][Full Text] [Related]
53. Monocyte activation in patients with Hodgkin's disease.
Kávai M; Berényi E; Zsindely A; Szegedi G; Fésüs L
Int J Cancer; 1984 Oct; 34(4):483-5. PubMed ID: 6149193
[TBL] [Abstract][Full Text] [Related]
54. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
[TBL] [Abstract][Full Text] [Related]
55. Analysis of circulating immune complexes (CICs) in childhood tuberculosis: levels of specific antibodies to glycolipid antigens and relationship with serum antibodies.
Simonney N; Bourrillon A; Lagrange PH
Int J Tuberc Lung Dis; 2000 Feb; 4(2):152-60. PubMed ID: 10694094
[TBL] [Abstract][Full Text] [Related]
56. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
[TBL] [Abstract][Full Text] [Related]
57. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
58. Distinguishing features of the immunology of Hodgkin's disease in children.
Tan CT; De Sousa M; Good RA
Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
[TBL] [Abstract][Full Text] [Related]
59. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
60. The immunologic consequences of laparoscopy in oncology.
Carter JJ; Whelan RL
Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
